Ipsen
Ipsen is a global biopharmaceutical company that improves patients’ lives through research, innovation and the development of transformative medicines.
With employees in over 40 countries and partners delivering medicines to patients in over 100 countries worldwide, Ipsen is the manufacturer of an injectable form of botulinum toxin type A (or botulinum toxin A), which is registered in over 90 countries worldwide.
Or botulinum toxin A acts at the neuromuscular junction, blocking the release of acetylcholine and thereby reducing muscle spasm.
Aesthetic indications:
- glabellar wrinkles;
- lateral periorbital wrinkles;
- primary axillary hyperhidrosis.
Read also
- Aesthetic medicine of the mammary glands: algorithms for choosing professional care
- Sebum, hormones and the role of microflora in the pathogenesis of acne
- Correction of microelementosis in EM: enhancing the results of professional procedures
- DERMA 2026: networking and knowledge that builds trust.
- Sensitivity or inflammation? A differential approach in choosing professional care
- How to treat body acne?
- Between the procedure and the result: home care as the key to prolonged effectiveness
- Dynamic care: strategies for changing protocols according to skin age stages
- Banning ingredients in cosmetics. Part 2